Bixiye
QP31-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Metformin ER
Taariikhda uu dhaqangalayo Barnaamijka: May 04, 2018
Natiijooyinka Raadinta
Soo bandhiga 2881 - 2890 ee natiijooyinka 4130
Bixiye
QP53-18 Medical Drug Policy Criteria Expanded for Stelara and Simponi Aria
Taariikhda wax ku ool ah ee barnaamijka: Jun 27, 2018
Bixiye
QP23-18 Pharmacy Benefit Exclusion for Crysvita
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2018
Bixiye
QP36-18 Pre-Admission Notification Update Effective May 21, 2018
Taariikhda uu dhaqangalayo Barnaamijka: May 18, 2018
Bixiye
QP14-18 Pharmacy Benefit Exclusion for Fasenra
Taariikhda uu dhaqangalayo Barnaamijka: 19, Feb 2018
Bixiye
QP26-18 Predetermination Request Form for Commercial Lines of Business
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 19, 2018
Bixiye
QP47-17 Pharmacy Benefit Exclusion Mepsevii
Taariikhda uu dhaqangalayo Barnaamijka: Des 07, 2017
Bixiye
QP24-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Multiple Sclerosis (MS) Agents
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2018
Bixiye
QP49-17 State of MN Migrates to New Operating System
Taariikhda uu dhaqangalayo Barnaamijka: Des 07, 2017
Bixiye
QP64-18 Action Required: Apply for Designation as a Blue Distinction Center for Spine Surgery
Taariikhda barnaamijka Dhaqangalayso Agosto 14, 2018